Rochester Clinical Site 108 — Rochester, New York

Rochester Clinical Site 108 is a clinical research site located in Rochester, New York, United States 14642.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Rochester Clinical Site 108 has participated in 2 clinical trials.

Therapeutic areas: Multiple Sclerosis.

Sponsors: EMD Serono, Ono Pharma USA Inc.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rochester Clinical Site 108?

Rochester Clinical Site 108 has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rochester Clinical Site 108 conducted?

Rochester Clinical Site 108 has 2 clinical trials on record. Their work covers Multiple Sclerosis.

Is Rochester Clinical Site 108 accredited by Crixeo Health?

Rochester Clinical Site 108 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rochester Clinical Site 108?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.